Related Experiment Video
Updated: Apr 27, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration
Heying Chu, Hailan Luo, Huaqi Wang
1Department of Respiratory Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. zhaogq@zzu.edu.cn.
Background:
Bone morphogenetic protein 2 (BMP-2) is a member of the TGF-β superfamily that is closely correlated with many malignancies, particularly lung cancer. However, the effects of silenced BMP-2 on lung cancer cell proliferation and migration are not clear.
Methods:
Using quantitative real-time RT-PCR, BMP-2 mRNA expression was detected in 61 non-small cell lung cancer (NSCLC) samples. Survival curves were generated using follow-up data. Relationships between clinical or pathological characteristics and prognosis were analyzed. Cell viability assays and transwell migration assays were used to evaluate the effects of BMP-2 silencing on cell proliferation and migration of A549 and H460 cells.
Results:
BMP-2 mRNA expression was higher in NSCLC tissues compared to matched adjacent normal tissues (P<0.01). High BMP-2 expression levels were significantly associated with the occurrence of lymph node metastases and tumor stage (P<0.05). There were significant differences in survival curves between groups with metastatic lymph nodes and non-metastatic lymph nodes, as well as between groups with low BMP-2 expression and groups with high BMP-2 expression. In addition, we observed decreased proliferation and migration rates of the NSCLC-derived cell lines A549 and H460 that were transfected with siBMP-2 (P<0.05).
Conclusion:
BMP-2 mRNA is overexpressed in NSCLC samples and is a risk factor for survival in patients with NSCLC. BMP-2 silencing can significantly inhibit A549 and H460 cell proliferation and migration.
Virtual Slides:
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4263254471298866.
Insights
Bone morphogenetic protein 2 (BMP-2) is overexpressed in non-small cell lung cancer (NSCLC) and linked to poor survival. Silencing BMP-2 inhibits NSCLC cell proliferation and migration.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Bone morphogenetic protein 2 (BMP-2), a TGF-β superfamily member, is implicated in various cancers, including lung cancer.
- The specific role of BMP-2 in non-small cell lung cancer (NSCLC) cell proliferation and migration remains unclear.
Purpose of the Study:
- To investigate BMP-2 mRNA expression in NSCLC tissues.
- To determine the correlation between BMP-2 expression and clinical/pathological characteristics and prognosis in NSCLC patients.
- To evaluate the impact of BMP-2 silencing on NSCLC cell proliferation and migration.
Main Methods:
- Quantitative real-time RT-PCR was used to measure BMP-2 mRNA levels in 61 NSCLC samples.
- Survival analysis was performed using follow-up data.
- Cell viability and transwell migration assays assessed the effects of BMP-2 silencing (siBMP-2) in A549 and H460 cell lines.
Main Results:
- BMP-2 mRNA expression was significantly higher in NSCLC tissues than in adjacent normal tissues (P<0.01).
- Elevated BMP-2 levels correlated with lymph node metastasis and advanced tumor stage (P<0.05).
- BMP-2 silencing reduced proliferation and migration in A549 and H460 cells (P<0.05).
Conclusions:
- BMP-2 mRNA is overexpressed in NSCLC and serves as a prognostic risk factor.
- BMP-2 silencing effectively inhibits NSCLC cell proliferation and migration, suggesting its potential as a therapeutic target.
